FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 119 filers reported holding FATE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -96.4% | 500 | -94.1% | 0.00% | -100.0% |
| Q1 2022 | $329,000 | -55.0% | 8,500 | -32.0% | 0.00% | -66.7% |
| Q4 2021 | $731,000 | -30.7% | 12,500 | -29.8% | 0.00% | -25.0% |
| Q3 2021 | $1,055,000 | -31.7% | 17,800 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,544,000 | +18.6% | 17,800 | +12.7% | 0.01% | +20.0% |
| Q1 2021 | $1,302,000 | +30.2% | 15,800 | +43.6% | 0.01% | +25.0% |
| Q4 2020 | $1,000,000 | +383.1% | 11,000 | +111.5% | 0.00% | +300.0% |
| Q3 2020 | $207,000 | +125.0% | 5,200 | +92.6% | 0.00% | – |
| Q2 2020 | $92,000 | -94.1% | 2,700 | -96.6% | 0.00% | -100.0% |
| Q4 2019 | $1,565,000 | -37.0% | 80,000 | -50.0% | 0.01% | +40.0% |
| Q3 2019 | $2,484,000 | +53.0% | 160,000 | +100.0% | 0.01% | -28.6% |
| Q2 2019 | $1,624,000 | +15.6% | 80,000 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $1,405,000 | +36.9% | 80,000 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $1,026,000 | -22.4% | 80,000 | -1.5% | 0.01% | -16.7% |
| Q3 2018 | $1,322,000 | +43.7% | 81,200 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $920,000 | +751.9% | 81,200 | +631.5% | 0.00% | – |
| Q1 2018 | $108,000 | +61.2% | 11,100 | 0.0% | 0.00% | – |
| Q4 2017 | $67,000 | +55.8% | 11,100 | 0.0% | 0.00% | – |
| Q3 2017 | $43,000 | +22.9% | 11,100 | 0.0% | 0.00% | – |
| Q2 2017 | $35,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |